$Spero Therapeutics, Inc.(SPRO)$ 8-K - Current report Filed: 2018-07-17 AccNo: 0001193125-18-219722 Size: 101 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接